Improving Diagnosis and Outcomes in Rheumatoid Arthritis: The Key Role of Primary Care

Activity Details
  • Credit Amounts:
  • Cost: Free
  • Release: Jul 28, 2016
  • Expires: Jul 27, 2017
  • Average User Rating:
    ( Ratings)

Needs Statement


As the US care system experiences an increase in demand for services due to an aging population, management of rheumatoid arthritis (RA) is continuing a shift from the domain of rheumatology specialists to the co-management with, or individual management by, primary care practitioners. This program aims to help general practitioners and family medicine practitioners recognize the early signs of RA and refer to or otherwise work with rheumatology specialists.

 

Target Audience

Primary care phyisicians, nurse practitioners, nurses, physician assistants, and other heathcare providers who treat patients with RA

 

Objectives

After completing this activity, the participant will demonstrate the ability to:

  • Discuss the early signs and symptoms of RA and provide timely referral to rheumatology specialty care when appropriate
  • Outline practical, evidence-based approaches for diagnosis and management that reflect recent advances in treatment
  • Increase awareness of evidence-based recommendations on the therapeutic role of biologics, especially emerging data on TNF inhibitors and their use in early/aggressive therapy

 

 

Accreditation

How to Participate

Click on the link to the right. By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.00 AMA PRA Category 1 CreditTM, and nurses are entitled to receive 1.00 CNE contact hour, all of which is pharmacology credit worthy. Statement of credit will be available to print immediately. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the post-test and activity evaluation.
  • Physicians and nurses who successfully complete the post-test and evaluation will respectively receive CME or CNE. You must score with a 70% or higher on the post-test to receive credit for this activity.
  • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

ACCME:

Boston Univeristy School of MEdicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Boston University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

ANCC:

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

CNE Contact Hours: 1.00, all of which is pharmacology credit worthy. 

Nurses will receive contact hours after completion of the post test, evaluation and claim for credit form
 
 

Faculty Disclosure

 

CONFLICT OF INTEREST DISCLOSURE POLICY

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relevant relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices occurs
Dr. York, CME Course Director, has nothing to disclose with regard to commercial interests.

Dr. Doghramji is on the speaker’s bureau for Takeda, Merck, Teva and AstraZeneca. He is also on the advisory board for AstraZeneca.

Ms. Figueiredo, CNE Course Advisor, has nothing to disclose with regard to commercial interests.
 

Planning Committee and Reviewer Disclosure:

Reviewer report the following relationship(s):
Dr. Wiecha
 has nothing to disclose with regard to commercial interests.

Elizabeth Drury
, Program Manager, Dana Frazier, Grant Manager, Patti-Ann Collins, DNP, MSN/MBA, RN, Lead Nurse Planner, and Joshua F. Kilbridge, Medical Writer, have no relevant financial relationships to disclose.